I'm sure you're well aware of activist investors like Bill Ackman entering the pharma sector and significantly impacting health care M&A. It seems that a lot of the effects of these transactions significantly reduce investment on research and development, yet have thrived. Do you think that this trend is sustainable, and what do effects do you project this trend having on the future of pharmaceutical innovation?
Again, thank you so much for taking the time to be here.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.